...
首页> 外文期刊>Protein Expression and Purification >Heterologous expression of soluble, active proteins in Escherichia coli: The human estrogen receptor hormone-binding domain as paradigm
【24h】

Heterologous expression of soluble, active proteins in Escherichia coli: The human estrogen receptor hormone-binding domain as paradigm

机译:可溶性,活性蛋白在大肠杆菌中的异源表达:以人雌激素受体激素结合结构域为范式

获取原文
获取原文并翻译 | 示例
           

摘要

The human estrogen receptor ligand-binding domain (hER-E/F), including the distal F domain, has been expressed to high levels in a soluble, active form in Escherichia coli in order to facilitate biophysical studies. The ability of a series of vectors incorporating strong transcriptional and translational signals to provide an efficient expression system for hER-E/F was investigated. High-level expression was obtained from all of the vectors used in the study. Although the majority of hER-E/F protein was produced in insoluble form under standard bacterial culture conditions, hER-E/F could be produced in soluble, biologically active form by altering the sequence of the expressed protein and by varying the host culture conditions. Several parameters, including the presence of a His tag, growth temperature, and addition of ethanol and 17 beta -estradiol to the growth medium were shown to have a positive effect on production of soluble hER-E/F. An optimized expression system capable of producing from 25 to 35 mg of biologically active hER-E/F in 1 liter of cell culture was designed, and a simple, rapid purification protocol for hER-E/F produced in this system was developed. Characterization of purified hER-E/F by Edman degradation and mass spectrometry verified the identity of the protein. The K-D for 17 beta -estradiol binding to purified hER-E/F was determined to be 0.6 +/- 0.1 nM. The parameters controlling soluble, heterologous protein production observed in this study may be generally applicable to the expression of other heterologous proteins in E. coli. (C) 2001 Academic Press. [References: 24]
机译:人类雌激素受体配体结合结构域(hER-E / F),包括远侧F结构域,已在大肠杆菌中以可溶性,活性形式高水平表达,以促进生物物理研究。研究了掺入强转录和翻译信号的一系列载体为hER-E / F提供有效表达系统的能力。从研究中使用的所有载体均获得了高水平表达。尽管大多数hER-E / F蛋白是在标准细菌培养条件下以不溶形式产生的,但hER-E / F可以通过改变表达蛋白的序列和改变宿主培养条件以可溶性,生物活性形式产生。包括His标签的存在,生长温度以及向生长培养基中添加乙醇和17β-雌二醇的几个参数显示对可溶性hER-E / F的产生具有积极作用。设计了一种能够在1升细胞培养物中产生25-35 mg的生物活性hER-E / F的优化表达系统,并开发了一种简单,快速的纯化方法,用于在该系统中生产hER-E / F。通过Edman降解和质谱法对纯化的hER-E / F进行表征,验证了该蛋白的身份。测定17β-雌二醇与纯化的hER-E / F结合的K-D为0.6 +/- 0.1nM。在这项研究中观察到的控制可溶性异源蛋白质生产的参数通常可适用于大肠杆菌中其他异源蛋白质的表达。 (C)2001学术出版社。 [参考:24]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号